PapersFlow Research Brief
Soft tissue tumors and treatment
Research Guide
What is Soft tissue tumors and treatment?
Soft tissue tumors and treatment refers to the clinical, molecular, and genetic study of neoplasms arising from muscle, fat, connective tissue, and related structures, including glomus tumors and their atypical and malignant variants, with emphasis on diagnosis via imaging, surgical resection, and associations with conditions like neurofibromatosis type 1.
The field encompasses 12,065 published works on soft tissue tumors. Key references include comprehensive texts like "Enzinger and Weiss's Soft Tissue Tumors" by Sharon W. Weiss and John R. Goldblum (2001) and "Soft Tissue Tumors" by Franz M. Enzinger, Sharon W. Weiss, and B. Chandrasekhar (1985), which detail pathology of tumors from muscle, fat, and connective tissue. Advances cover histopathological grading as in Trojani et al. (1984) and the 2020 WHO classification by Sbaraglia, Bellan, and Dei Tos (2020).
Topic Hierarchy
Research Sub-Topics
Glomus Tumor Histopathology
This sub-topic examines the microscopic features, immunohistochemical markers, and differential diagnosis of benign and malignant glomus tumors in soft tissues. Researchers study atypical variants and their classification per WHO guidelines.
Genetic Mutations in Glomus Tumors
This sub-topic investigates somatic and germline mutations, particularly in NF1 and other genes, underlying glomus tumor pathogenesis. Researchers analyze associations with neurofibromatosis type 1 and familial syndromes.
Radiological Imaging of Glomus Tumors
This sub-topic covers MRI, CT, and ultrasound characteristics for detecting and localizing glomus tumors, especially in extremities and viscera. Researchers evaluate imaging specificity for preoperative planning.
Surgical Treatment of Glomus Tumors
This sub-topic explores microsurgical excision techniques, recurrence rates, and management of malignant variants across anatomical sites. Researchers compare outcomes of wide local excision versus conservative approaches.
Gastrointestinal Glomus Tumors
This sub-topic focuses on the clinicopathological features, endoscopic diagnosis, and endoscopic or surgical resection of glomus tumors in the stomach and intestines. Researchers study their malignant potential and prognostic factors.
Why It Matters
Soft tissue tumors require precise diagnosis and multidisciplinary management to enable limb-conserving surgery and radiotherapy, reducing reliance on amputation, as outlined in "Soft-Tissue Sarcomas in Adults" by Clark et al. (2005). Guidelines in "Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up" by Gronchi et al. (2021) standardize care for adults, improving outcomes through wide excisional surgery and chemotherapy for advanced cases. Associations with neurofibromatosis type 1, addressed in "Guidelines for the diagnosis and management of individuals with neurofibromatosis 1" by Ferner et al. (2006), highlight genetic screening needs, with NF1 patients facing diverse complications like glomus tumors managed via molecular insights and neuroimaging.
Reading Guide
Where to Start
"Enzinger and Weiss's Soft Tissue Tumors" by Sharon W. Weiss and John R. Goldblum (2001) serves as the foundational reference, offering comprehensive coverage of soft tissue tumor pathology suitable for initial reading.
Key Papers Explained
"Enzinger and Weiss's Soft Tissue Tumors" by Weiss and Goldblum (2001) and "Soft Tissue Tumors" by Enzinger, Weiss, and Chandrasekhar (1985) establish core pathological descriptions, which Trojani et al. (1984) builds upon with a histopathological grading system from 155 cases; Sbaraglia, Bellan, and Dei Tos (2020) update this in the WHO classification, while Clark et al. (2005) and Gronchi et al. (2021) extend to clinical management.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Recent classification updates in "The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives" by Sbaraglia et al. (2020) and ESMO guidelines by Gronchi et al. (2021) direct focus toward refined mesenchymal tumor diagnostics and personalized treatments, with no new preprints available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Enzinger and Weiss's Soft Tissue Tumors | 2001 | — | 2.4K | ✕ |
| 2 | Soft Tissue Tumors | 1985 | Plastic & Reconstructi... | 2.3K | ✕ |
| 3 | TEEATMENT OF CARCINOMA OF THE AMPULLA OF VATER | 1935 | Annals of Surgery | 1.4K | ✓ |
| 4 | The Diagnostic Evaluation and Multidisciplinary Management of ... | 1997 | JAMA | 1.3K | ✕ |
| 5 | Soft‐tissue sarcomas of adults; study of pathological prognost... | 1984 | International Journal ... | 1.3K | ✕ |
| 6 | Lever's Histopathology of the Skin | 1998 | Archives of Dermatology | 1.1K | ✕ |
| 7 | Guidelines for the diagnosis and management of individuals wit... | 2006 | Journal of Medical Gen... | 1.0K | ✓ |
| 8 | The 2020 WHO Classification of Soft Tissue Tumours: news and p... | 2020 | Pathologica | 925 | ✓ |
| 9 | Soft-Tissue Sarcomas in Adults | 2005 | New England Journal of... | 882 | ✕ |
| 10 | Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clini... | 2021 | Annals of Oncology | 866 | ✓ |
Frequently Asked Questions
What are the main diagnostic approaches for soft tissue tumors?
Diagnosis involves radiological imaging, histopathological grading, and molecular analysis. "Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system" by Trojani et al. (1984) uses criteria like tumor differentiation, cellularity, nuclear atypia, and mitosis. The 2020 WHO Classification by Sbaraglia et al. (2020) refines mesenchymal tumor categorization for better pathologic accuracy.
How are soft tissue sarcomas treated in adults?
Treatment centers on wide excisional surgery combined with radiotherapy, reserving chemotherapy for advanced disease. "Soft-Tissue Sarcomas in Adults" by Clark et al. (2005) emphasizes multidisciplinary care with limb-conserving approaches. ESMO guidelines by Gronchi et al. (2021) provide protocols for diagnosis, treatment, and follow-up of soft tissue and visceral sarcomas.
What is the role of neurofibromatosis type 1 in soft tissue tumors?
Neurofibromatosis type 1 associates with glomus tumors and other soft tissue neoplasms. "The Diagnostic Evaluation and Multidisciplinary Management of Neurofibromatosis 1 and Neurofibromatosis 2" by Gutmann (1997) proposes comprehensive diagnosis and treatment strategies. "Guidelines for the diagnosis and management of individuals with neurofibromatosis 1" by Ferner et al. (2006) detail autosomal dominant inheritance and variable complications aided by molecular biology.
What updates occurred in soft tissue tumor classification?
The 2020 WHO Classification updates schemes for mesenchymal tumors, enhancing diagnostic quality and therapeutic options. "The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives" by Sbaraglia, Bellan, and Dei Tos (2020) highlights refinements in pathology. Earlier works like "Enzinger and Weiss's Soft Tissue Tumors" by Weiss and Goldblum (2001) provide foundational pathology.
What pathological features predict prognosis in soft tissue sarcomas?
Prognostic variables include tumor differentiation, cellularity, nuclear atypia, and mitotic activity. Trojani et al. (1984) studied 155 adult patients to define a grading system based on these features. Such grading aids in treatment planning as referenced in ESMO guidelines by Gronchi et al. (2021).
Open Research Questions
- ? How do genetic mutations in glomus tumors influence malignant transformation?
- ? What imaging modalities best differentiate atypical glomus tumors from benign variants?
- ? Which surgical approaches optimize outcomes for gastrointestinal glomus tumors?
- ? How does neurofibromatosis type 1 modify treatment responses in associated soft tissue sarcomas?
Recent Trends
The field has 12,065 works with emphasis on WHO updates in "The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives" by Sbaraglia, Bellan, and Dei Tos (2020, 925 citations) and clinical guidelines in Gronchi et al. (2021, 866 citations), refining diagnosis and management amid associations with neurofibromatosis type 1.
Research Soft tissue tumors and treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Soft tissue tumors and treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers